Pharma

Your Article Summary

See Latest Articles

Pandemic (H1N1) 2009 Influenza Update: GSKs H1N1 Pandemrix vaccine receives European Commission Approval
GlaxoSmithKline, 10/01/09

GlaxoSmithKline confirmed that the European Commission has granted marketing authorisation of GSK's pandemic (H1N1) adjuvanted vaccine Pandemrix™ for protection against pandemic H1N1 2009 influenza.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis gains rights to two oral targeted investigational therapies focusing on patients with life-threatening blood disorders and cancers
Novartis, 11/29/09

Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/29/09

Human genome sciences submits biologics license application to fda for zalbin
Human Genome Sciences, 11/29/09

 See all of Drug/Product Approvals